Return to AD Clinical Trials Search Results Return to AD Clinical Trials Home
Purpose: To evaluate the effects of AC-1204 on cognition, activities of daily living, quality of life, pharmacokinetic measures, and safety in people with mild to moderate Alzheimer's disease.
Return to AD Clinical Trials Search Results
Return to AD Clinical Trials Home